Cholinergic inhibition of adrenergic transmission.
D000109:Acetylcholine / Q000494:pharmacology*; D000320:Adrenergic Fibers / Q000187:drug effects; D000818:Animals; D001808:Blood Vessels / Q000294:innervation*; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000294:innervation*; D009411:Nerve Endings / Q000187:drug effects; D009433:Neural Inhibition; D009638:Norepinephrine / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects*; D014439:Tyramine / Q000494:pharmacology
D011942:Receptors, Adrenergic, alpha; D011976:Receptors, Muscarinic; D000109:Acetylcholine; D011188:Potassium; D009638:Norepinephrine; D014439:Tyramine